share_log

In8bio | CORRESP: CORRESP

SEC announcement ·  Jan 16 12:28
Summary by Moomoo AI
In8bio, Inc., a biotechnology company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company has proposed for the Registration Statement to become effective at 4:00 p.m. Eastern time on January 18, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended. In8bio's legal counsel, Cooley LLP, may reach out to the SEC staff to confirm the effective time or to request a different time if necessary. The company has designated Sarah Curry of Cooley LLP to be notified once the Registration Statement is declared effective by the SEC.
In8bio, Inc., a biotechnology company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company has proposed for the Registration Statement to become effective at 4:00 p.m. Eastern time on January 18, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended. In8bio's legal counsel, Cooley LLP, may reach out to the SEC staff to confirm the effective time or to request a different time if necessary. The company has designated Sarah Curry of Cooley LLP to be notified once the Registration Statement is declared effective by the SEC.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more